Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

220 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses.
Thompson GR 3rd, Rendon A, Ribeiro Dos Santos R, Queiroz-Telles F, Ostrosky-Zeichner L, Azie N, Maher R, Lee M, Kovanda L, Engelhardt M, Vazquez JA, Cornely OA, Perfect JR. Thompson GR 3rd, et al. Clin Infect Dis. 2016 Aug 1;63(3):356-62. doi: 10.1093/cid/ciw305. Epub 2016 May 11. Clin Infect Dis. 2016. PMID: 27169478 Free PMC article. Clinical Trial.
Empirical antimicrobial therapy for traveler's diarrhea.
Adachi JA, Ostrosky-Zeichner L, DuPont HL, Ericsson CD. Adachi JA, et al. Clin Infect Dis. 2000 Oct;31(4):1079-83. doi: 10.1086/318119. Epub 2000 Oct 25. Clin Infect Dis. 2000. PMID: 11049792 Review.
Amphotericin B: time for a new "gold standard".
Ostrosky-Zeichner L, Marr KA, Rex JH, Cohen SH. Ostrosky-Zeichner L, et al. Clin Infect Dis. 2003 Aug 1;37(3):415-25. doi: 10.1086/376634. Epub 2003 Jul 22. Clin Infect Dis. 2003. PMID: 12884167
Voriconazole salvage treatment of invasive candidiasis.
Ostrosky-Zeichner L, Oude Lashof AM, Kullberg BJ, Rex JH. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2003 Nov;22(11):651-5. doi: 10.1007/s10096-003-1014-3. Epub 2003 Oct 17. Eur J Clin Microbiol Infect Dis. 2003. PMID: 14564539
Combination antifungal therapy.
Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. Johnson MD, et al. Antimicrob Agents Chemother. 2004 Mar;48(3):693-715. doi: 10.1128/AAC.48.3.693-715.2004. Antimicrob Agents Chemother. 2004. PMID: 14982754 Free PMC article. Review. No abstract available.
International, open-label, noncomparative, clinical trial of micafungin alone and in combination for treatment of newly diagnosed and refractory candidemia.
Ostrosky-Zeichner L, Kontoyiannis D, Raffalli J, Mullane KM, Vazquez J, Anaissie EJ, Lipton J, Jacobs P, van Rensburg JH, Rex JH, Lau W, Facklam D, Buell DN. Ostrosky-Zeichner L, et al. Eur J Clin Microbiol Infect Dis. 2005 Oct;24(10):654-61. doi: 10.1007/s10096-005-0024-8. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16261306 Clinical Trial.
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial.
Kuse ER, Chetchotisakd P, da Cunha CA, Ruhnke M, Barrios C, Raghunadharao D, Sekhon JS, Freire A, Ramasubramanian V, Demeyer I, Nucci M, Leelarasamee A, Jacobs F, Decruyenaere J, Pittet D, Ullmann AJ, Ostrosky-Zeichner L, Lortholary O, Koblinger S, Diekmann-Berndt H, Cornely OA; Micafungin Invasive Candidiasis Working Group. Kuse ER, et al. Lancet. 2007 May 5;369(9572):1519-1527. doi: 10.1016/S0140-6736(07)60605-9. Lancet. 2007. PMID: 17482982 Clinical Trial.
220 results